RedHill Biopharma (RDHL) Shares Issued (2012 - 2022)

RedHill Biopharma (RDHL) has 8 years of Shares Issued data on file, last reported at $7.6 million in Q4 2022.

• Shares Issued for Q4 2022 came in at $7.6 million, down 61.74% year-over-year; the trailing twelve-month figure through Dec 2022 was $23.8 million (down 69.69% YoY), and the FY2025 annual result was $7.8 million, down 6.04% from the prior year.
• Shares Issued slipped to $7.6 million in Q4 2022 per RDHL's latest filing, from $15.5 million in the prior quarter.
• Over five years, Shares Issued peaked at $57.9 million in Q1 2021 and troughed at $273000.0 in Q2 2021.
• A 4-year average of $13.0 million and a median of $8.4 million in 2020 frame the typical range for Shares Issued.
• On a YoY basis, Shares Issued climbed as much as 5580.59% in 2022 and fell as far as 98.77% in 2022.
• A 4-year view of Shares Issued shows it stood at $18.4 million in 2018, then slumped by 54.53% to $8.4 million in 2020, then jumped by 136.92% to $19.8 million in 2021, then tumbled by 61.74% to $7.6 million in 2022.
• Business Quant data shows RDHL's Shares Issued at $7.6 million in Q4 2022, $15.5 million in Q2 2022, and $713000.0 in Q1 2022.